Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 24041717)

1.

Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.

Buoli M, Serati M, Altamura AC.

J Affect Disord. 2014 Jan;152-154:12-8. doi: 10.1016/j.jad.2013.08.024. Epub 2013 Aug 31. Review.

PMID:
24041717
2.

Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis.

Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU.

Expert Opin Drug Saf. 2015 Jun 24:1-19. [Epub ahead of print]

PMID:
26107820
3.

Management of Adverse Effects of Mood Stabilizers.

Murru A, Popovic D, Pacchiarotti I, Hidalgo D, León-Caballero J, Vieta E.

Curr Psychiatry Rep. 2015 Aug;17(8):603. doi: 10.1007/s11920-015-0603-z.

PMID:
26084665
4.

[Acute delirium in decompensated schizophrenia and bipolar disorder].

Faget-Agius C, Lançon C.

Rev Prat. 2015 Feb;65(2):235-40. French.

PMID:
25939232
5.

Hyperprolactinemia and medications for bipolar disorder: Systematic review of a neglected issue in clinical practice.

Pacchiarotti I, Murru A, Kotzalidis GD, Bonnin CM, Mazzarini L, Colom F, Vieta E.

Eur Neuropsychopharmacol. 2015 Apr 14. pii: S0924-977X(15)00107-8. doi: 10.1016/j.euroneuro.2015.04.007. [Epub ahead of print] Review.

PMID:
25937241
6.

Improving outcomes in patients with bipolar depression: a comprehensive review.

Nierenberg AA, McIntyre RS, Sachs GS.

J Clin Psychiatry. 2015 Mar;76(3):e10. doi: 10.4088/JCP.13091ip1. Review.

7.

Is duration of illness really influencing outcome in major psychoses?

Altamura AC, Serati M, Buoli M.

Nord J Psychiatry. 2015 Aug;69(6):403-17. doi: 10.3109/08039488.2014.990919. Epub 2015 Mar 13.

PMID:
25768662
8.

Managing bipolar II disorder: some personal perspectives.

Parker G.

Australas Psychiatry. 2015 Apr;23(2):116-9. doi: 10.1177/1039856214568219. Epub 2015 Feb 5.

PMID:
25657304
9.

[Treatment of bipolar disorder].

Barde M, Bellivier F.

Rev Prat. 2014 Nov;64(9):1195-202. Review. French.

PMID:
25638852
10.

[The use of mood stabilizers in preventive treatment of patients with schizoaffective disorders].

Chritinin DF, Sumarokova MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):63-7. Russian.

PMID:
25591519
11.

Review of lithium effects on immune cells.

Maddu N, Raghavendra PB.

Immunopharmacol Immunotoxicol. 2015 Apr;37(2):111-25. doi: 10.3109/08923973.2014.998369. Epub 2015 Jan 5.

PMID:
25559226
12.

Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study.

Malempati RN.

J Nerv Ment Dis. 2015 Jan;203(1):58-64. doi: 10.1097/NMD.0000000000000234.

PMID:
25536100
13.

Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.

Bauer M, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Severus E, Ritter P, Whybrow PC.

Int J Bipolar Disord. 2013 May 3;1:5. doi: 10.1186/2194-7511-1-5. eCollection 2013.

14.

Controversies in the psychopharmacology of bipolar disorder.

Post RM, Ostacher MJ, Singh V.

J Clin Psychiatry. 2014 Nov;75(11):e30. doi: 10.4088/JCP.13095tx2cj. Review.

15.

Pros and cons of approved therapies for bipolar depression and ongoing unmet needs.

McElroy SL.

J Clin Psychiatry. 2014 Oct;75(10):e26. doi: 10.4088/JCP.13019tx4c.

16.

Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.

Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY.

J Clin Psychiatry. 2014 Sep;75(9):e924-31. doi: 10.4088/JCP.13m08843.

PMID:
25295435
17.

Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.

Calabrese JR, Fava M, Garibaldi G, Grunze H, Krystal AD, Laughren T, Macfadden W, Marin R, Nierenberg AA, Tohen M.

J Affect Disord. 2014 Oct;168:439-51. doi: 10.1016/j.jad.2014.06.056. Epub 2014 Jul 10.

PMID:
25113957
18.

Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.

Dell'Osso B, Cremaschi L, Palazzo MC, Spagnolin G, Cattaneo A, Grancini B, Maggi M, Altamura AC.

Expert Opin Drug Saf. 2014 Sep;13(9):1199-208. doi: 10.1517/14740338.2014.938047. Epub 2014 Aug 1. Review.

PMID:
25084462
19.

Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.

Amerio A, Odone A, Marchesi C, Ghaemi SN.

J Affect Disord. 2014 Sep;166:258-63. doi: 10.1016/j.jad.2014.05.026. Epub 2014 May 28. Review.

PMID:
25012439
20.

Pharmacological treatments in gambling disorder: a qualitative review.

Lupi M, Martinotti G, Acciavatti T, Pettorruso M, Brunetti M, Santacroce R, Cinosi E, Di Iorio G, Di Nicola M, Di Giannantonio M.

Biomed Res Int. 2014;2014:537306. doi: 10.1155/2014/537306. Epub 2014 May 18. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk